
Marketsand Markets
Articles
-
1 month ago |
agribusinessglobal.com | FMC Corp |Marketsand Markets |Matt Hopkins
Syngenta has announced the names of three foliar-applied insecticide brands for its in-season insect management portfolio in the U.S. today. Upon approval by the Environmental Protection Agency, these foliar insecticide products are anticipated to manage insect pests in cotton, vegetables, tree fruit crops and more.
-
1 month ago |
croplife.com | Dan Jacobs |Marketsand Markets
History, knowledge and maybe a little bit of luck. Planning how to treat insect and disease pressures is an ongoing and difficult task for retailers and their grower-customers. The myriad variables that influence pest infestations are hard, if not impossible, to predict. The 2025 season will be no different. Manufacturers of products designed to combat the multiple challenges growers face continue to deliver new and effective solutions.
-
1 month ago |
agribusinessglobal.com | Marketsand Markets |Matt Hopkins
FMC Corporation has announced it has received registration in Brazil for Sofero Fall pheromone targeting fall armyworm (Spodoptera frugiperda). Sofero Fall is the first in the company’s lineup of distinctive pheromone products for row crops offering growers a novel approach to sustainably control pests, manage resistance and boost productivity.
-
2 months ago |
outsourcedpharma.com | Sampatkumarr Govind Donthula |Marketsand Markets |Louis Garguilo
Guest Column | March 18, 2025 By Sampatkumarr Govind Donthula, MarketsandMarkets Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone that stimulates insulin secretion, gene expression, and ß-cell proliferation. The U.S. FDA has approved dipeptidyl peptidase-4 (DPP-IV) resistant long-acting GLP-1s as injectable drugs for treating patients with type 2 diabetes.
-
Jan 18, 2025 |
whatech.com | Marketsand Markets
GenScript (China) announced the expansion of its Singapore facility to provide a premium gene synthesis service. This marks a significant expansion of the company's advanced gene-synthesis capability and enables GenScript to provide the service levels required for novel vaccine and therapeutics development in life sciences.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →